ID.1
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
ID.2
Item
stable treatment with oral anti-diabetic drugs (metformin, sulphonylurea or a combination of both) for at least 3 months at the discretion of the investigator
boolean
C0935929 (UMLS CUI [1])
ID.3
Item
hba1c equal to or greater than 7.0% and equal to or lower than 11.0%
boolean
C0019018 (UMLS CUI [1])
ID.4
Item
body mass index (bmi) equal to or lower than 45.0 kg/m2
boolean
C1305855 (UMLS CUI [1])
ID.5
Item
previous treatment with insulin
boolean
C0557978 (UMLS CUI [1])
ID.6
Item
treatment with any anti-diabetic drug other than metformin and sulphonylurea
boolean
C0935929 (UMLS CUI [1,1])
C0025598 (UMLS CUI [1,2])
C0038766 (UMLS CUI [1,3])
ID.7
Item
any previous exposure to exenatide or liraglutide
boolean
C0167117 (UMLS CUI [1,1])
C1456408 (UMLS CUI [1,2])
ID.8
Item
impaired liver or/and renal function
boolean
C0232741 (UMLS CUI [1,1])
C0232804 (UMLS CUI [1,2])
ID.9
Item
history of any significant cardiac events
boolean
C0741923 (UMLS CUI [1])
ID.10
Item
known retinopathy or maculopathy requiring acute treatment
boolean
C0035309 (UMLS CUI [1,1])
C0339471 (UMLS CUI [1,2])
ID.11
Item
recurrent major hypoglycaemia or hypoglycaemic unawareness
boolean
C0150254 (UMLS CUI [1])